Marc Lecomte
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
Papers in
-
- Protein Degradation and Inhibitors 2
-
- Advanced Glycation End Products research 6
- Co-authors
- Nicolas Wiernsperger (7 shared papers)Michel Lagarde (6 shared papers)Daniel Ruggiero-Lopez (2 shared papers)Daniel Ruggiero (4 shared papers)Christophe Paget (2 shared papers)Gerard. Moinet (1 shared paper)William L. Smith (2 shared papers)Dipak K. Bhattacharyya (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Molecular Pharmaceutics (2 papers)Free Radical Biology and Medicine (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Marc Lecomte
19 papers receiving 736 citations
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 274
- Endocrinology, Diabetes and Metabolism 185
- Pharmacology 164
- Biochemistry 65
- Ophthalmology 71
Countries citing papers authored by Marc Lecomte
This map shows the geographic impact of Marc Lecomte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lecomte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lecomte more than expected).
Fields of papers citing papers by Marc Lecomte
This network shows the impact of papers produced by Marc Lecomte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lecomte. The network helps show where Marc Lecomte may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Lecomte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 197 | |
| 2 | 1996 | 158 | |
| 3 | 2002 | 117 | |
| 4 | 1998 | 77 | |
| 5 | 1998 | 40 | |
| 6 | 1999 | 37 | |
| 7 | 2019 | 24 | |
| 8 | 2009 | 21 | |
| 9 | 2004 | 15 | |
| 10 | 2009 | 13 | |
| 11 | 2019 | 12 | |
| 12 | 2012 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2022 | 7 | |
| 15 | 2025 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 1995 | 5 | |
| 18 | 2000 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2025 | 0 |
About Marc Lecomte
Marc Lecomte is a scholar working on Molecular Biology, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Ophthalmology and Oncology, having authored 21 papers that have together received 758 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Retinal Diseases and Treatments (4 papers), Hormonal Regulation and Hypertension (3 papers), Drug Solubulity and Delivery Systems (2 papers), Peptidase Inhibition and Analysis (2 papers), Protein Degradation and Inhibitors (2 papers), Nanoplatforms for cancer theranostics (2 papers) and Natural Antidiabetic Agents Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (274 citations), Endocrinology, Diabetes and Metabolism (185 citations), Pharmacology (164 citations), Biochemistry (65 citations) and Ophthalmology (71 citations). Marc Lecomte has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Nicolas Wiernsperger, Michel Lagarde, Daniel Ruggiero-Lopez, Daniel Ruggiero, Christophe Paget, Gerard. Moinet, William L. Smith, Dipak K. Bhattacharyya, R. Michael Garavito and Caroline Jill Rieke. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Pharmaceutics, Free Radical Biology and Medicine, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.